Stay updated on Cabotegravir+VRC-HIVMAB075 in HIV-1 Viral Suppression Clinical Trial
Sign up to get notified when there's something new on the Cabotegravir+VRC-HIVMAB075 in HIV-1 Viral Suppression Clinical Trial page.

Latest updates to the Cabotegravir+VRC-HIVMAB075 in HIV-1 Viral Suppression Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.0%
- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedThe webpage has been updated to reflect a new version of the study protocol, including the addition of collaborators and investigators, and the removal of detailed descriptions of the study's purpose and methodology. The revision number has also changed from v2.14.4 to v2.15.0.SummaryDifference51%
- Check30 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.0%
- Check37 days agoChange DetectedThe web page has been updated from version 2.14.2 to version 2.14.3.SummaryDifference0.0%
- Check73 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference0.8%
- Check87 days agoChange DetectedThe page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with a contact email for assistance.SummaryDifference0.8%
Stay in the know with updates to Cabotegravir+VRC-HIVMAB075 in HIV-1 Viral Suppression Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cabotegravir+VRC-HIVMAB075 in HIV-1 Viral Suppression Clinical Trial page.